bullish
HK Inno.N (INNO KS): On a Solid Growth Path with Blockbuster New Drug K-CAB
Tina has highlighted this Insight as a Top Pick
497 Views19 Nov 2021 09:46
SUMMARY
- HK inno.N (INNO KS)'s new digestive disease drug K-CAB is the only drug of its class available in Korean market and has superior efficacy than the current standard of care.
- K-CAB has already become the no. 1 drug in Korean digestive treatment market. HK inno plans to further strengthen its position by expanding global presence and increasing indication approvals.
- From this year, HK inno has started distributing Merck’s seven vaccines, including its largest selling HPV vaccine 'Gardasil' in Korea. The company also has a rich pipeline of innovative drugs.
Related Insights
More »- Korea Value-Up Index Drops on the 24th: Hunt for the Winners in the KOSDAQ Global Index
- HK Inno.N (195940 KS): 2024 Will See Robust Profit Growth On Growing Momentum of Key Drug
- HK Inno.N (195940 KS): 2Q23 Result Shows Strong Sequential Improvement; K-CAB Continues to Fly High
- HK Inno. N (195940 KS): Flagship Drug K-CAB Is Set to Become a Global Blockbuster Drug
- HK Inno.N (INNO KS): On a Solid Growth Path with Blockbuster New Drug K-CAB
Trending Collections
More »Trending Insights
More »- Weekly Deals Digest (04 May) - Toyota Industries, Shibaura, Dickson, HKBN, Meilan Airport, Soundwill
- CATL H Share Listing: AH Discount Views
- Smartpay (SPY NZ/SMP AU): Three Is No Crowd as a Third Bid Lands at NZ$1.20
- Last Week in Event SPACE: Toyota, Rio Tinto, Hainan Meilan, Fujitsu General
- Singapore: Lawrence Wong Boosted by Mild Improvement in PAP Vote Share
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- HK Inno.N (195940 KS): 2024 Will See Robust Profit Growth On Growing Momentum of Key Drug23 Apr 2024
- HK Inno.N (195940 KS): 2Q23 Result Shows Strong Sequential Improvement; K-CAB Continues to Fly High03 Aug 2023
- HK Inno. N (195940 KS): Flagship Drug K-CAB Is Set to Become a Global Blockbuster Drug23 May 2022
- HK Inno.N (INNO KS): On a Solid Growth Path with Blockbuster New Drug K-CAB19 Nov 2021
- HK Inno.N Post-Listing Immediate Float Analysis04 Aug 2021
- HK Inno.N (Formerly CJ Healthcare) IPO: Offering Detail & Valuation Issues07 Jul 2021
- HK Inno.N IPO Valuation Analysis05 Jul 2021
x